IL246794B - No-releasing nitrooxy-chromene conjugates - Google Patents

No-releasing nitrooxy-chromene conjugates

Info

Publication number
IL246794B
IL246794B IL246794A IL24679416A IL246794B IL 246794 B IL246794 B IL 246794B IL 246794 A IL246794 A IL 246794A IL 24679416 A IL24679416 A IL 24679416A IL 246794 B IL246794 B IL 246794B
Authority
IL
Israel
Prior art keywords
nitrooxy
chromane
conjugates
release
group
Prior art date
Application number
IL246794A
Other languages
English (en)
Hebrew (he)
Other versions
IL246794A0 (en
Original Assignee
Euclises Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euclises Pharmaceuticals Inc filed Critical Euclises Pharmaceuticals Inc
Publication of IL246794A0 publication Critical patent/IL246794A0/en
Publication of IL246794B publication Critical patent/IL246794B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL246794A 2014-01-14 2016-07-14 No-releasing nitrooxy-chromene conjugates IL246794B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461927344P 2014-01-14 2014-01-14
PCT/US2015/011454 WO2015109011A1 (en) 2014-01-14 2015-01-14 No-releasing nitrooxy-chromene conjugates

Publications (2)

Publication Number Publication Date
IL246794A0 IL246794A0 (en) 2016-08-31
IL246794B true IL246794B (en) 2020-04-30

Family

ID=53543408

Family Applications (1)

Application Number Title Priority Date Filing Date
IL246794A IL246794B (en) 2014-01-14 2016-07-14 No-releasing nitrooxy-chromene conjugates

Country Status (10)

Country Link
US (1) US10266511B2 (https=)
EP (1) EP3094333B1 (https=)
CN (1) CN106102747A (https=)
AU (1) AU2015206528B2 (https=)
BR (1) BR112016016386B1 (https=)
CA (1) CA2936952C (https=)
ES (1) ES2836374T3 (https=)
IL (1) IL246794B (https=)
MX (1) MX369245B (https=)
WO (2) WO2015109011A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105585547A (zh) * 2016-03-09 2016-05-18 中国科学院广州生物医药与健康研究院 一种4-五氟化硫苯酚类化合物及制备方法以及五氟化硫取代苯并吡喃类化合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050101563A1 (en) 2001-08-14 2005-05-12 Pharmacia Corporation Method and compositions for the treatment and prevention of pain and inflammation
ITMI20021391A1 (it) 2002-06-25 2003-12-29 Nicox Sa Nitroderivati di inibitori della cicloossigenasi-2
EP1562914A1 (en) 2002-10-22 2005-08-17 Merck Frosst Canada & Co. Nitric oxide releasing selective cyclooxygenase-2 inhibitors
EP1603933A2 (en) * 2003-03-13 2005-12-14 Nitromed, Inc. Nitrosated and nitrosylated compounds, compositions and methods of use
US7259266B2 (en) 2003-03-31 2007-08-21 Pharmacia Corporation Benzopyran compounds useful for treating inflammatory conditions
US20050148627A1 (en) 2003-03-31 2005-07-07 Jeffery Carter Benzopyran compounds for use in the treatment and prevention of inflammation related conditions
EP1692107A4 (en) * 2003-12-10 2008-10-29 Nitromed Inc NITROGEN OXIDE-RELATED PYRUVATE COMPOUNDS, COMPOSITIONS AND USE METHOD
WO2006040646A1 (en) * 2004-10-14 2006-04-20 Pfizer, Inc. Benzimidazole or indole amides as inhibitors of pin1
WO2009009776A2 (en) 2007-07-12 2009-01-15 Tragara Pharmaceuticals, Inc. Patient selection and therapeutic methods using markers of prostaglandin metabolism
CN103012350B (zh) * 2012-12-07 2015-02-04 中国科学院广州生物医药与健康研究院 苯并吡喃类手性化合物的合成方法

Also Published As

Publication number Publication date
EP3094333A4 (en) 2017-09-06
MX2016009222A (es) 2017-03-06
EP3094333B1 (en) 2020-10-14
CA2936952C (en) 2023-01-24
CN106102747A (zh) 2016-11-09
US20160340330A1 (en) 2016-11-24
WO2015109013A1 (en) 2015-07-23
CA2936952A1 (en) 2015-07-23
ES2836374T3 (es) 2021-06-24
BR112016016386B1 (pt) 2023-02-23
BR112016016386A2 (https=) 2017-08-08
AU2015206528B2 (en) 2019-04-18
MX369245B (es) 2019-11-01
WO2015109011A1 (en) 2015-07-23
IL246794A0 (en) 2016-08-31
EP3094333A1 (en) 2016-11-23
US10266511B2 (en) 2019-04-23
AU2015206528A1 (en) 2016-08-04

Similar Documents

Publication Publication Date Title
FIC20230006I1 (fi) Vutrisiraani
IL285516B (en) Amatoxin antibody conjugates
LT3525830T (lt) Pirolbenzodiazepino konjugatai
EP3313857A4 (en) POLYMER-CYCLODEXTRIN LIPID CONJUGATES
DK3466976T3 (da) Anti-her2-antistof-lægemiddelkonjugat
DK3119885T3 (da) Antistof-fynomer-konjugater
LT3230281T (lt) 1,3-tiazol-2-ilu pakeisti benzamidai
DK3209778T3 (da) Kombination
DK3148591T3 (da) Nanopartikel-lægemiddelkonjugater
GB201513607D0 (en) Pyrrolobenzodiazepine-antibody conjugates
KR20180084876A (ko) 내플라즈마성 부재
DK3544634T3 (da) MET-antistof-lægemiddelkonjugater
DE102015122969A8 (de) Selbstsperrender Mechanismus
EP3341425A4 (en) Polyvinyl butyral G-polylactide COPOLYMER
EP3541403A4 (en) LIGAND-IONOPHORE CONJUGATES
SE1700204A1 (sv) Clutch
EP3463423A4 (en) GLUCAGON-T3 CONJUGATES
EP3341022A4 (en) CONJUGATES
PT3270711T (pt) Conjugados açúcar-dipéptido
DE112015003601A5 (de) Antriebsstrang
IL246794B (en) No-releasing nitrooxy-chromene conjugates
ITUB20152982A1 (it) Innesto rapido
GB201621467D0 (en) Modified bulgeomers
UA35827S (uk) Бланк
GB201616374D0 (en) Modified bulgeomers

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed